<scp>CD4</scp> <sup>+</sup> T Cells Mediate Dendritic Cell Licensing to Promote Multi‐Antigen Anti‐Leukemic Immune Response
Together these findings support a CD4+ T cell-mediated mechanism of DC licensing to promote multi-Ag immune responses that may augment current targeted immunotherapies and avoid relapses in treated children with ALL.
Authors
- Luis Gil‐de‐Gómez (ORCID: https://orcid.org/0000-0002-7864-3976)
- Jessica H. Lee (ORCID: https://orcid.org/0000-0001-8643-1773)
- Alix E. Seif (ORCID: https://orcid.org/0000-0002-1799-2582)
- Gregor S. D. Reid (ORCID: https://orcid.org/0000-0002-7567-3424)
- Stephan A. Grupp (ORCID: https://orcid.org/0000-0001-8030-7595)
- Jane Mattei
Institutions
- Universidad de Cantabria (ES)
- Children's Hospital of Philadelphia (US)
- University of British Columbia (CA)
- BC Children's Hospital (CA)
- University of Pennsylvania (US)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-12-27
- DOI
- https://doi.org/10.1002/cam4.70508
- Citations
- 1
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- Hyundai Hope On Wheels